Resources for Food and Drug Administration (FDA)
FDA fast-tracks first cocaine, meth addiction fighter
www.suntimes.com Deerfield-based Ovation Pharmaceuticals said Tuesday its drug vigabatrin, being developed to treat cocaine and methamphetamine dependence, has landed “fast track” designation from U.S. regulators potentially speeding up the process for market approval.
The drug would be the first approved by the U.S. Food and Drug Administration for treatment of the addictions.
The anticonvulsant drug, to be marketed under the brand name Sabril, is believed to block the craving and euphoria associated with cocaine and meth use. It is thought to work by increasing brain levels of so-called gamma-aminobutyric acid, a transmitter that inhibits certain activity in the brain.
View the Resource
Share or bookmarklet this web page at:
|
RSS Feeds
